Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Sogo Rinsho Holdings Co Ltd

+ Add to Watchlist

2399:JP

460.0 JPY 0.00.00%

As of 01:00:00 ET on 01/30/2015.

Snapshot for Sogo Rinsho Holdings Co Ltd (2399)

Open: 460.0 Day's Range: 457.0 - 460.0 Volume: 11,400
Previous Close: 460.0 52wk Range: 431.0 - 553.0 1-Yr Rtn: -11.56%

Stock Chart for 2399

No chart data available.
  • 2399:JP 460.0
  • 1D
  • 1M
  • 1Y
460.0
Interactive 2399 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2399

Current P/E Ratio (ttm) 36.0473
Estimated P/E(07/2015) 16.3121
Relative P/E vs. TPX 2.2658
Earnings Per Share (JPY) (ttm) 12.7610
Est. EPS (JPY) (07/2015) 28.2000
Est. PEG Ratio -
Market Cap (M JPY) 9,912.08
Shares Outstanding (M) 21.55
30 Day Average Volume 39,800
Price/Book (mrq) 1.8870
Price/Sale (ttm) 1.5458
Dividend Indicated Gross Yield 2.17%
Cash Dividend (JPY) 5.0000
Dividend Ex-Date 07/29/2015
5 Year Dividend Growth 10.76%
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2399

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 2399

Sogo Rinsho Holdings Co.,Ltd. is a site management organization (SMO). The Company assists clinical trials conducted by medical institutions that are to develop pharmaceutical products.

Haruo NishinoChairmanYukihiro SasakiVice Chairman
Noriyuki TachikawaPresidentToshiya HashimotoDirector
More Company Profile & Key Executives for 2399

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil